-
FDA permits marketing of AI-based device to detect diabetic retinopathy
europeanpharmaceuticalreview
April 17, 2018
The FDA has permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy…
-
Novartis announces new analysis demonstrating Entresto helped preserve kidney function in patients with chronic heart failure, especially those with diabetes
firstwordpharma
April 17, 2018
Novartis today announced a new post hoc analysis of the pivotal Phase III heart failure study
-
UK team develops novel skin patch for diabetes
biospectrumasia
April 16, 2018
The patch does not pierce the skin, instead it draws glucose out from fluid between cells across hair follicles.
-
UK team develops novel skin patch for diabetes
biospectrumasia
April 16, 2018
The patch does not pierce the skin, instead it draws glucose out from fluid between cells across hair follicles.
-
Adhesive patch offers bloodless diabetes monitoring
europeanpharmaceuticalreview
April 13, 2018
Scientists have created a non-invasive, adhesive patch, which promises the measurement of glucose levels through the skin without a finger-prick blood test…
-
ARKAY Therapeutics Submits Investigational New Drug (IND) Application for RK-01, a First-in Class ‘Beta-cell-centric’ Drug Combination Product for Type 2 Diabetes
biospace
April 12, 2018
First Human Proof-of-Concept (PoC) Trial to Test the Superiority of RK-01 over Metformin in Type 2 Diabetes Patients with Inadequate Glycemic Control.
-
ReShape Lifesciences Pioneers New Bio-electronic Technology for Treatment of Type 2 Diabetes
biospace
April 11, 2018
ReShape Lifesciences Inc. announced today that the Company will be presenting early results of a new, novel use of the ReShape Lifesciences™ neuro-blocking technology in combination with separate-site vagus nerve stimulation for the treatment of type 2
-
Lilly and Sigilon to collaborate on cell encapsulation for diabetes
pharmaceutical-technolog
April 09, 2018
Eli Lilly and Sigilon Therapeutics have announced a strategic collaboration to develop encapsulated cell therapies for type 1 diabetes.
-
Eating Pecans May Cut Risk of Cardiovascular Disease, Diabetes
drugs
April 09, 2018
Eating pecans every day for four weeks improves certain markers of cardiometabolic disease risk, according to a study published online March 11 in Nutrients.
-
EMA to review Sanofi’s type I diabetes therapy
pharmatimes
March 30, 2018
The European Medicines Agency has accepted for review Sanofi's experimental type I diabetes therapy sotagliflozi.